2015
DOI: 10.3390/molecules20022857
|View full text |Cite
|
Sign up to set email alerts
|

Ring-Opening Polymerization of ε-Caprolactone Initiated by Ganciclovir (GCV) for the Preparation of GCV-Tagged Polymeric Micelles

Abstract: Ganciclovir (GCV) is a nucleoside analogue with antiviral activity against herpes viral infections, and the most widely used antiviral to treat cytomegalovirus infections. However, the low bioavailability and short half-life of GCV necessitate the development of a carrier for sustained delivery. In this study, guanosine-based GCV was used as the initiator directly in ring-opening polymerization of ε-caprolactone (ε-CL) to form hydrophobic GCV-poly(caprolactone) (GCV-PCL) which was then grafted with hydrophilic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
22
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 13 publications
(22 citation statements)
references
References 25 publications
0
22
0
Order By: Relevance
“…In contrast, the viability of HT-29 cells was decreased to 60% when challenged with 2 mg mL −1 5’-DFUR-PCL-MPEG micelles for 72 h (Figure 8B). In prior work, it has been shown that HT-29 cells treated with polymeric micelles tagged with acyclovir (ACV) [49] or ganciclovir (GCV) [51] did not exhibit apparent toxicity. This is because ACV and GCV prodrugs are not converted to their active and toxic form by TP.…”
Section: Resultsmentioning
confidence: 99%
“…In contrast, the viability of HT-29 cells was decreased to 60% when challenged with 2 mg mL −1 5’-DFUR-PCL-MPEG micelles for 72 h (Figure 8B). In prior work, it has been shown that HT-29 cells treated with polymeric micelles tagged with acyclovir (ACV) [49] or ganciclovir (GCV) [51] did not exhibit apparent toxicity. This is because ACV and GCV prodrugs are not converted to their active and toxic form by TP.…”
Section: Resultsmentioning
confidence: 99%
“…The synthesis of GCV–PCL–chitosan and MPEG 350 –PCL–chitosan amphiphilic polymers in this study was previously reported [ 27 ]. In brief, 50 mg of GCV was mixed with 2.25 mL of ε-caprolactone (ε-CL) for 5 min at room temperature, followed by the addition of Sn(Oct) 2 (0.5 wt% of ε-CL).…”
Section: Methodsmentioning
confidence: 99%
“…PCL is commonly synthesized by ring-opening polymerization of ε-caprolactone using alcohol (R-OH) as an initiator and stannous (II) octoate (Sn(Oct) 2 ) as a catalyst [ 25 , 26 ]. Prodrug GCV possessing hydroxyl groups was employed as the initiator to synthesize GCV–PCL by ring-opening polymerization of ε-caprolactone [ 27 ]. The reported liphophilic GCV–PCL were further grafted with hydrophilic biodegradable chitosan which has been widely accepted as an efficient vector for nonviral gene delivery by forming complexes with DNA plasmids [ 28 , 29 ].…”
Section: Introductionmentioning
confidence: 99%
“…In recent years, a number of new Cs derivatives with improved transfection efficiency and better water solubility have been synthesized and characterized for drug and gene delivery. For example, urocanic acid-modified, 5 hydrophobized, 6 , 7 glycosylated, 8 polyethylene glycol-modified (PEGylated), 9 , 10 trimethylated, 11 , 12 poly(amidoamine) (PAMAM) grafted, 13 , 14 poly(epsilon-caprolactone) grafted, 15 , 16 oligoamine grafted, 17 and glycol grafted Cs 18 , 19 have been characterized using in vitro and in vivo models. These modified Cs derivatives have distinct advantages and disadvantages when used as the drug and gene delivery systems or theranostics.…”
Section: Introductionmentioning
confidence: 99%